About Nymox Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is a biopharmaceutical company specializing in the research and development of therapeutics and diagnostics for the aging population.Nymox has an extensive pipeline of products under development, including therapeutics for enlarged prostate (BPH), a common affliction of males over the age of 50, and for Alzheimer s disease, the most common cause of dementia in the elderly. The company has global patent rights for the use of statins to treat or prevent Alzheimer’s disease. Nymox also has therapeutics in development for other indications, including deadly E. coli O157 food contamination, a major public health concern.Nymox developed and now markets AlzheimAlert™, the only accurate urine test that can help in the diagnosis of Alzheimer’s disease. Nymox markets AlzheimAlert™ in the U.S. as a reference laboratory test and in the E.U. as a CE-marked kit for hospitals and laboratories in Europe.
Nymox Pharmaceutical Corporation is Saint-laurent-based company (Quebec, Canada) with a phone number 8009369669. Our data show that the company is located at the address: 9900 Cavendish Boulevard St-Laurent. The company has a web site: www.nymox.com.
Unfortunately сompany staff has not yet provided of company's activities, mission and detailed description.